Efficacy and safety of the proprotein convertase subtilisin/kexin type 9 inhibitor alirocumab among high cardiovascular risk patients on maximally tolerated statin therapy: The ODYSSEY COMBO I study
Kereiakes, Dean J., MD, FACC, FSCAI, Robinson, Jennifer G., MD, MPH, Cannon, Christopher P., MD, Lorenzato, Christelle, MSc, Pordy, Robert, MD, Chaudhari, Umesh, MD, Colhoun, Helen M., MD, MFPHM, FRCP(Ed)
Published in The American heart journal (01.06.2015)
Published in The American heart journal (01.06.2015)
Get full text
Journal Article
Efficacy and Safety of Alirocumab in Reducing Lipids and Cardiovascular Events
Robinson, Jennifer G, Farnier, Michel, Krempf, Michel, Bergeron, Jean, Luc, Gérald, Averna, Maurizio, Stroes, Erik S, Langslet, Gisle, Raal, Frederick J, El Shahawy, Mahfouz, Koren, Michael J, Lepor, Norman E, Lorenzato, Christelle, Pordy, Robert, Chaudhari, Umesh, Kastelein, John J.P
Published in The New England journal of medicine (16.04.2015)
Published in The New England journal of medicine (16.04.2015)
Get full text
Journal Article
Effect of a monoclonal antibody to PCSK9, REGN727/SAR236553, to reduce low-density lipoprotein cholesterol in patients with heterozygous familial hypercholesterolaemia on stable statin dose with or without ezetimibe therapy: a phase 2 randomised controlled trial
Stein, Evan A, Prof, Dr, Gipe, Dan, MD, Bergeron, Jean, MD, Gaudet, Daniel, Prof, Weiss, Robert, MD, Dufour, Robert, MD, Wu, Richard, PhD, Pordy, Robert, MD
Published in The Lancet (British edition) (07.07.2012)
Published in The Lancet (British edition) (07.07.2012)
Get full text
Journal Article
ANGPTL3 Inhibition in Homozygous Familial Hypercholesterolemia
Gaudet, Daniel, Gipe, Daniel A, Pordy, Robert, Ahmad, Zahid, Cuchel, Marina, Shah, Prediman K, Chyu, Kuang-Yuh, Sasiela, William J, Chan, Kuo-Chen, Brisson, Diane, Khoury, Etienne, Banerjee, Poulabi, Gusarova, Viktoria, Gromada, Jesper, Stahl, Neil, Yancopoulos, George D, Hovingh, G. Kees
Published in The New England journal of medicine (20.07.2017)
Published in The New England journal of medicine (20.07.2017)
Get full text
Journal Article
Efficacy and safety of alirocumab vs ezetimibe in statin-intolerant patients, with a statin rechallenge arm: The ODYSSEY ALTERNATIVE randomized trial
Moriarty, Patrick M., MD, Thompson, Paul D., MD, Cannon, Christopher P., MD, Guyton, John R., MD, Bergeron, Jean, MD, Zieve, Franklin J., MD, PhD, Bruckert, Eric, MD, Jacobson, Terry A., MD, Kopecky, Stephen L., MD, Baccara-Dinet, Marie T., MD, Du, Yunling, PhD, Pordy, Robert, MD, Gipe, Daniel A., MD
Published in Journal of clinical lipidology (01.11.2015)
Published in Journal of clinical lipidology (01.11.2015)
Get full text
Journal Article
A randomized study investigating the safety, tolerability, and pharmacokinetics of evinacumab, an ANGPTL3 inhibitor, in healthy Japanese and Caucasian subjects
Harada-Shiba, Mariko, Ali, Shazia, Gipe, Daniel A., Gasparino, Evelyn, Son, Vladimir, Zhang, Yi, Pordy, Robert, Catapano, Alberico L.
Published in Atherosclerosis (01.12.2020)
Published in Atherosclerosis (01.12.2020)
Get full text
Journal Article
Evinacumab: Mechanism of action, clinical, and translational science
Dingman, Robert, Bihorel, Sébastien, Gusarova, Viktoria, Mendell, Jeanne, Pordy, Robert
Published in Clinical and translational science (01.06.2024)
Published in Clinical and translational science (01.06.2024)
Get full text
Journal Article
Effect of alirocumab on cataracts in patients with acute coronary syndromes
Suc, Gaspard, Schwartz, Gregory G, Goodman, Shaun G, Jukema, J Wouter, Manvelian, Garen, Poulouin, Yann, Pordy, Robert, Scemama, Michel, Szarek, Michael, Steg, Ph Gabriel
Published in BMC ophthalmology (16.06.2023)
Published in BMC ophthalmology (16.06.2023)
Get full text
Journal Article
Correction: Effect of alirocumab on cataracts in patients with acute coronary syndromes
Suc, Gaspard, Schwartz, Gregory G, Goodman, Shaun G, Jukema, J Wouter, Manvelian, Garen, Poulouin, Yann, Pordy, Robert, Scemama, Michel, Szarek, Michael, Steg, Ph Gabriel
Published in BMC ophthalmology (06.07.2023)
Published in BMC ophthalmology (06.07.2023)
Get full text
Journal Article
Effect of proprotein convertase subtilisin/kexin type 9 inhibition on cancer events: A pooled, post hoc, competing risk analysis of alirocumab clinical trials
Mohammadi, Kusha A., Brackin, Taylor, Schwartz, Gregory G., Steg, Philippe Gabriel, Szarek, Michael, Manvelian, Garen, Pordy, Robert, Fazio, Sergio, Geba, Gregory P.
Published in Cancer medicine (Malden, MA) (01.08.2023)
Published in Cancer medicine (Malden, MA) (01.08.2023)
Get full text
Journal Article
Lower On-Treatment Low-Density Lipoprotein Cholesterol and Major Adverse Cardiovascular Events in Women and Men: Pooled Analysis of 10 ODYSSEY Phase 3 Alirocumab Trials
Vallejo-Vaz, Antonio J, Ginsberg, Henry N, Davidson, Michael H, Eckel, Robert H, Cannon, Christopher P, Lee, L Veronica, Bessac, Laurence, Pordy, Robert, Letierce, Alexia, Ray, Kausik K
Published in Journal of the American Heart Association (18.09.2018)
Published in Journal of the American Heart Association (18.09.2018)
Get full text
Journal Article
THE IMPACT OF EVINACUMAB THERAPY ON PEDIATRIC PATIENTS WITH HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA: RESULTS FROM PART B OF A PHASE 3 TRIAL
Wiegman, Albert, Greber-Platzer, Susanne, Ali, Shazia, Singh, Divya, Reijman, M. Doortje, Brinton, Eliot A, Charng, Min-Ji, Srinivasan, Shubha, Baker-Smith, Carissa, Baum, Seth, Brothers, Julie, Hartz, Jacob, Moriarty, Patrick M., Banerjee, Poulabi, George, Richard T, Pordy, Robert
Published in American journal of preventive cardiology (01.09.2023)
Published in American journal of preventive cardiology (01.09.2023)
Get full text
Journal Article
Effect of Alirocumab on Mortality After Acute Coronary Syndromes
Steg, Philippe Gabriel, Szarek, Michael, Bhatt, Deepak L, Bittner, Vera A, Brégeault, Marie-France, Dalby, Anthony J, Diaz, Rafael, Edelberg, Jay M, Goodman, Shaun G, Hanotin, Corinne, Harrington, Robert A, Jukema, J Wouter, Lecorps, Guillaume, Mahaffey, Kenneth W, Moryusef, Angèle, Ostadal, Petr, Parkhomenko, Alexander, Pordy, Robert, Roe, Matthew T, Tricoci, Pierluigi, Vogel, Robert, White, Harvey D, Zeiher, Andreas M, Schwartz, Gregory G
Published in Circulation (New York, N.Y.) (09.07.2019)
Published in Circulation (New York, N.Y.) (09.07.2019)
Get full text
Journal Article
Alirocumab Treatment and Achievement of Non‐High‐Density Lipoprotein Cholesterol and Apolipoprotein B Goals in Patients With Hypercholesterolemia: Pooled Results From 10 Phase 3 ODYSSEY Trials
Bays, Harold E., Leiter, Lawrence A., Colhoun, Helen M., Thompson, Desmond, Bessac, Laurence, Pordy, Robert, Toth, Peter P.
Published in Journal of the American Heart Association (01.08.2017)
Published in Journal of the American Heart Association (01.08.2017)
Get full text
Journal Article
Pharmacologic and Genetic Downregulation of Proprotein Convertase Subtilisin/Kexin Type 9 and Survival From Sepsis
Lawler, Patrick R., Manvelian, Garen, Coppi, Alida, Damask, Amy, Cantor, Michael N., Ferreira, Manuel A. R., Paulding, Charles, Banerjee, Nilanjana, Li, Dadong, Jorgensen, Susan, Attre, Richa, Carey, David J., Krebs, Kristi, Milani, Lili, Hveem, Kristian, Damås, Jan K., Solligård, Erik, Stender, Stefan, Tybjærg-Hansen, Anne, Nordestgaard, Børge G., Hernandez-Beeftink, Tamara, Rogne, Tormod, Flores, Carlos, Villar, Jesús, Walley, Keith R., Liu, Vincent X., Fohner, Alison E., Lotta, Luca A., Kyratsous, Christos A., Sleeman, Mark W., Scemama, Michel, DelGizzi, Richard, Pordy, Robert, Horowitz, Julie E., Baras, Aris, Martin, Greg S., Steg, Philippe Gabriel, Schwartz, Gregory G., Szarek, Michael, Goodman, Shaun G.
Published in Critical care explorations (08.11.2023)
Published in Critical care explorations (08.11.2023)
Get full text
Journal Article
Safety and Efficacy of Evinacumab, A Monoclonal Antibody to ANGPTL3, In Homozygous Familial Hypercholesterolemia
Gaudet, Daniel, MD, PhD, Gipe, Daniel, MD, Hovingh, Kees, MD, PhD, Ahmad, Zahid, MD, Cuchel, Marina, MD, PhD, Shah, Prediman, MD, Chyu, Kuang-Yuh, MD, PhD, Pordy, Robert, MD, FACP, Sasiela, William, PhD, Chan, Kuo-Chen, PhD, Khoury, Etienne, PhD
Published in Journal of clinical lipidology (01.05.2017)
Published in Journal of clinical lipidology (01.05.2017)
Get full text
Journal Article
Safety and efficacy of evinacumab, a monoclonal antibody to ANGPTL3, in patients with homozygous familial hypercholesterolemia receiving concomitant lipid-lowering therapies
Gaudet, Daniel, MD, PhD, Gipe, Daniel A., MD, Pordy, Robert, MD, FACP, Sasiela, William, PhD, Chan, Kuo-Chen, PhD, Khoury, Etienne, PhD
Published in Journal of clinical lipidology (01.05.2016)
Published in Journal of clinical lipidology (01.05.2016)
Get full text
Journal Article
Inverse Relationship Between Major Adverse Cardiovascular Events and non-High-Density Lipoprotein Cholesterol and Apolipoprotein B in Phase 3 Trials of Alirocumab
Davidson, Michael H., MD, Cannon, Christopher P., MD, Ginsberg, Henry N., MD, Pordy, Robert, MD, Bessac, Laurence, MD, Minini, Pascal, PhD, Eckel, Robert H., MD, Ray, Kausik K., BSc
Published in Journal of clinical lipidology (01.05.2016)
Published in Journal of clinical lipidology (01.05.2016)
Get full text
Journal Article
Evaluation of ventricular arrhythmias in early clinical pharmacology trials and potential consequences for later development
Min, Sherene S., MD, MPH, Turner, J. Rick, PhD, Nada, Adel, MD, MS, DiMino, Tara L., MD, Hynie, Ivo, MD, PhD, Kleiman, Robert, MD, Kowey, Peter, MD, Krucoff, Mitchell W., MD, Mason, Jay W., MD, Phipps, Alex, PhD, Newton-Cheh, Christopher, MD, MPH, Pordy, Robert, MD, Strnadova, Colette, PhD, Targum, Shari, MD, Uhl, Kathleen, MD, Finkle, John, MD
Published in The American heart journal (01.05.2010)
Published in The American heart journal (01.05.2010)
Get full text
Journal Article